Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Public health

Outside the Lab Clinical trials

Too Pregnant to Participate

| Roisin McGuigan

Are current ethical guidelines for clinical studies letting pregnant women down?

Outside the Lab Neuroscience

Undoing the Damage

| Roisin McGuigan

Two drugs have shown potential to reverse brain damage in mice following alcohol exposure in the womb

Disease Area Diagnostics & prognostics

Good on Paper

| Andres W. Martinez

As we develop new POCTs for resource-limited settings, the humble sheet of paper has a lot to offer.

Disease Area Public health

Hurdles to HIV Survival

| Roisin McGuigan

Why are so many patients with HIV still dying too young?

Outside the Lab Clinical trials

Doing More with Less

| Raffaella Ravinetto

How can we best utilize equipment and resources in low-income regions?

Outside the Lab Public health

Change is Here, But Are We Ready For it?

| Giorgio Stanta

Patient-centric healthcare can only be fully achieved if we change the current organizational methods

Outside the Lab Public health

Accessing Big Pharma's Conscience

| Jayasree K. Iyer

Jayasree K. Iyer, Executive Director of Access to Medicine Foundation, the Netherlands

Outside the Lab Professional development

Speed Versus Safety for Cell Therapy

| Karen Nichols and Jacques Galipeau

We want faster translation of cell therapies, but is it worth sacrificing public trust?

Outside the Lab Immunology

Cold War

| James Strachan

A vaccine against the common cold has long eluded us, but now researchers are on its track

Outside the Lab Cancer

A Personnel Story

| Rasha Kelej

The human element is key to tackle rising cancer rates in Africa

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register